27 апреля, 2022

Trends in global cardiovascular health

Cardiovascular disease is the leading cause of death worldwide; High blood pressure, high cholesterol, dietary hazards and air pollution are the leading causes of cardiovascular disease worldwide Cardiovascular disease (CVD) remains the leading cause of death worldwide, according to a new special issue of Journal of the American College of Cardiology (JACC). The issue analyzes […]

7 апреля, 2022

DGHO 2022 – Young cancer patients also suffer financial losses

Key messages In a survey of predominantly female patients suffering from cancer, 2/3 reported financial losses. These amounted to an average of € 500 per month two years after diagnosis. Background About 5% of all cancer patients are between 19 and 39 years old. In addition to physical and psychological stress, these people often have […]

2 апреля, 2022

Asthma, a misunderstood disease?

Patients With asthma diagnoses they tend to downplay their condition and misuse oral corticosteroids. To bring out this not very comforting picture is the analysis of a survey on how patients interpret the diagnosis they have received and on what behaviors they adopt in everyday life. The results obtained suggest that there is a problem […]

30 марта, 2022

Colorectal cancer, an appeal for prevention from the Campus Bio-Medico

(Adnkronos Salute) – In Italy, colorectal cancers represent the second most common neoplasm in women and the third in men. According to the Aiom report “The numbers of cancer in Italy”, 48,100 new cases (26,000 in men and 22,100 in women) are estimated in 2022, up from 1.5% and 1.6% respectively compared to 2020. Only […]

24 марта, 2022

Increasing maternal mortality in the U.S. during the pandemic

A new study shows that maternal mortality in the U.S. increased faster in 2021 than in 2020 and nearly doubled from pre-pandemic rates in 2019. American Indians/Alaska Natives endured the largest increase in pregnancy-related deaths. Boston University School of Public Health Following the emergence of the highly contagious Delta and Omicron COVID-19 variants, pregnancy-related death […]

20 марта, 2022

A new chance for resistant hypertension

The results of the phase 2 BrigHTN study demonstrate that baxdrostat significantly lowers blood pressure in patients with resistant hypertension. Unlike other molecules previously tested, baxdrostat inhibits aldosterone synthesis without inhibiting cortisol synthesis. If efficacy and safety are confirmed in phase 3, it could become the prototype of the first new class of antihypertensive drugs […]

11 марта, 2022

Chiusura Managed Entry Agreements (MEA) Registro Daklinza

AIFA Agenzia Italiana del Farmaco Chiusura Managed Entry Agreements (MEA) Registro Daklinza Si informano gli utenti dei Registri farmaci sottoposti a monitoraggio che, a partire dal , le procedure di applicazione degli accordi di condivisione del rischio, ovvero i Managed Entry Agreements (MEA), non sono più attive per il registro DAKLINZA per la seguente indicazione […]

7 марта, 2022

G-BA: Current benefit assessments in oncology

The The Federal Joint Committee (G-BA) has passed three new decisions on the benefit assessment compared to a respective appropriate comparator therapy in the field of oncology:  Trastuzumab Deruxtecan  (Enhertu, Daiichi Sankyo) as monotherapy for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer: Patients who have received prior treatment against HER2: […]

23 февраля, 2022

1,400 medical errors in the last year

Berlin (pag) – In the treatment error statistics for the year 2021, collected by the German Medical Association (BÄK), 1,416 treatment errors have been determined. Of these, 1,293 bear responsibility for damage to the patient’s health, in 180 cases there is a treatment error without causal damage to health.  Last year, the BÄK processed 5,324 […]